Cargando…

Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases

Bone metastases from prostate cancer (PCa) result from a complex cross-talk between PCa cells and osteoblasts (OB). Thus, targeting this interplay has become an attractive strategy to interfere with PCa bone dissemination. The agents currently used in clinical trials have proved ineffective, boostin...

Descripción completa

Detalles Bibliográficos
Autores principales: Antognelli, Cinzia, Marinucci, Lorella, Frosini, Roberta, Macchioni, Lara, Talesa, Vincenzo Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508123/
https://www.ncbi.nlm.nih.gov/pubmed/34638532
http://dx.doi.org/10.3390/ijms221910191
_version_ 1784582022221529088
author Antognelli, Cinzia
Marinucci, Lorella
Frosini, Roberta
Macchioni, Lara
Talesa, Vincenzo Nicola
author_facet Antognelli, Cinzia
Marinucci, Lorella
Frosini, Roberta
Macchioni, Lara
Talesa, Vincenzo Nicola
author_sort Antognelli, Cinzia
collection PubMed
description Bone metastases from prostate cancer (PCa) result from a complex cross-talk between PCa cells and osteoblasts (OB). Thus, targeting this interplay has become an attractive strategy to interfere with PCa bone dissemination. The agents currently used in clinical trials have proved ineffective, boosting research to identify additional mechanisms that may be involved in this two-directional talk. Here, we investigated whether and how 5-hydro-5-methylimidazolone (MG-H1), a specific methylglyoxal (MG)-derived advanced glycation end product (AGE), was a novel player in the dialogue between PCa and OB to drive PCa bone metastases. Conditioned medium from osteotropic PC3 PCa cells, pre-treated or not with a specific MG scavenger, was administrated to human primary OB and cell morphology, mesenchymal trans-differentiation, pro-osteogenic determinants, PCa-specific molecules, and migration/invasion were studied by phase-contrast microscopy, real-time PCR, western blot and specific assays, respectively. We found that PC3 cells were able to release MG-H1 that, by binding to the receptor for AGEs (RAGE) on OB, reprogrammed them into a less-differentiate phenotype, endowed with some PCa-specific molecular features and malignant properties, in a mechanism involving reactive oxidative species (ROS) production and NF-kB pathway activation. These findings provide novel insights into the mechanisms of PCa osteoblastic metastases and foster in vivo research toward new therapeutic strategies interfering with PCa/OB cross-talk.
format Online
Article
Text
id pubmed-8508123
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85081232021-10-13 Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases Antognelli, Cinzia Marinucci, Lorella Frosini, Roberta Macchioni, Lara Talesa, Vincenzo Nicola Int J Mol Sci Article Bone metastases from prostate cancer (PCa) result from a complex cross-talk between PCa cells and osteoblasts (OB). Thus, targeting this interplay has become an attractive strategy to interfere with PCa bone dissemination. The agents currently used in clinical trials have proved ineffective, boosting research to identify additional mechanisms that may be involved in this two-directional talk. Here, we investigated whether and how 5-hydro-5-methylimidazolone (MG-H1), a specific methylglyoxal (MG)-derived advanced glycation end product (AGE), was a novel player in the dialogue between PCa and OB to drive PCa bone metastases. Conditioned medium from osteotropic PC3 PCa cells, pre-treated or not with a specific MG scavenger, was administrated to human primary OB and cell morphology, mesenchymal trans-differentiation, pro-osteogenic determinants, PCa-specific molecules, and migration/invasion were studied by phase-contrast microscopy, real-time PCR, western blot and specific assays, respectively. We found that PC3 cells were able to release MG-H1 that, by binding to the receptor for AGEs (RAGE) on OB, reprogrammed them into a less-differentiate phenotype, endowed with some PCa-specific molecular features and malignant properties, in a mechanism involving reactive oxidative species (ROS) production and NF-kB pathway activation. These findings provide novel insights into the mechanisms of PCa osteoblastic metastases and foster in vivo research toward new therapeutic strategies interfering with PCa/OB cross-talk. MDPI 2021-09-22 /pmc/articles/PMC8508123/ /pubmed/34638532 http://dx.doi.org/10.3390/ijms221910191 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Antognelli, Cinzia
Marinucci, Lorella
Frosini, Roberta
Macchioni, Lara
Talesa, Vincenzo Nicola
Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases
title Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases
title_full Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases
title_fullStr Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases
title_full_unstemmed Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases
title_short Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases
title_sort metastatic prostate cancer cells secrete methylglyoxal-derived mg-h1 to reprogram human osteoblasts into a dedifferentiated, malignant-like phenotype: a possible novel player in prostate cancer bone metastases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508123/
https://www.ncbi.nlm.nih.gov/pubmed/34638532
http://dx.doi.org/10.3390/ijms221910191
work_keys_str_mv AT antognellicinzia metastaticprostatecancercellssecretemethylglyoxalderivedmgh1toreprogramhumanosteoblastsintoadedifferentiatedmalignantlikephenotypeapossiblenovelplayerinprostatecancerbonemetastases
AT marinuccilorella metastaticprostatecancercellssecretemethylglyoxalderivedmgh1toreprogramhumanosteoblastsintoadedifferentiatedmalignantlikephenotypeapossiblenovelplayerinprostatecancerbonemetastases
AT frosiniroberta metastaticprostatecancercellssecretemethylglyoxalderivedmgh1toreprogramhumanosteoblastsintoadedifferentiatedmalignantlikephenotypeapossiblenovelplayerinprostatecancerbonemetastases
AT macchionilara metastaticprostatecancercellssecretemethylglyoxalderivedmgh1toreprogramhumanosteoblastsintoadedifferentiatedmalignantlikephenotypeapossiblenovelplayerinprostatecancerbonemetastases
AT talesavincenzonicola metastaticprostatecancercellssecretemethylglyoxalderivedmgh1toreprogramhumanosteoblastsintoadedifferentiatedmalignantlikephenotypeapossiblenovelplayerinprostatecancerbonemetastases